RWE: Real-World Uses and the Regulatory and Access Forward Vision

Discussing the future of real-world evidence with key industry experts.

Dr. Scott Gottlieb, Former Commissioner of the Food and Drug Administration, and industry leaders met recently for a roundtable discussion with Parexel and Pharmaceutical Executive. They shared ideas and discussed opportunities and challenges regarding  the current and evolving role of real-world evidence (RWE) for regulatory approvals and drug development.

Please check out a series of videos from the discussion as well as the article resulting from the roundtable discussion.

Topics covered include:

  • Current state and future of RWE
  • RWE use cases
  • Data collection and need for transparency
  • Expansion of RWE with the oncology and rare diseases market 

Real-World Evidence: State of-the-Art Uses, Current Challenges and Future Vision

To stimulate a conversation about the current state and future of RWE, Pharmaceutical Executive, in collaboration with Parexel, brought together industry leaders in pharmaceutical development and clinical applications – including featured guest, Dr. Scott Gottlieb – for a roundtable discussion.

Read Now

We are always available for a conversation.


We are always available for a conversation.


Communication Preference

Communication Preference